Gay, Bisexual Men Report Higher Rates of Skin Cancer Than Heterosexual Men
the ONA take:
Gay and bisexual men indoor tan more frequently and report higher rates of skin cancer than heterosexual men, a new study published online ahead of print in JAMA Dermatology has shown.
Because indoor tanning, which is highly associated with skin cancer, has been suggested to be more common among sexual minority men compared with heterosexual men, researchers sought to evaluate whether skin cancer prevalence and indoor tanning behaviors differ by sexual orientation.
For the cross-sectional study, researchers analyzed data from the 2001, 2003, 2005, and 2009 California Health Interview Surveys and the 2013 National Health Interview Survey.
A total of 192,575 men and women 18 years or older identified as heterosexual or a sexual minority (homosexual, gay, or bisexual). Of those, 78,487 were heterosexual men, 3,083 were sexual minority men, 107,976 were heterosexual women, and 3,029 were sexual minority women.
Results showed that sexual minority men were more likely than heterosexual men to report having skin cancer and having tanned indoors, while sexual minority women were less likely than heterosexual women to report having tanned indoors and having had nonmelanoma skin cancer.
“Our hope is that this finding will help increase awareness among health care providers that gay and bisexual men constitute a high-risk population for skin cancer, which in turn will lead to increased public health education and more diligent skin cancer screening in this group of men,” Sarah Arron, MD, PhD, a UCSF associate professor of dermatology, said.
“Recent research suggests that, fortunately, screening can increase early detection and decrease mortality from this disease.”
Gay and bisexual men indoor tan more frequently and report higher rates of skin cancer than heterosexual men.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|